首页> 美国卫生研究院文献>Molecular Cancer >Comparative proteogenomic analysis of right-sided colon cancer left-sided colon cancer and rectal cancer reveals distinct mutational profiles
【2h】

Comparative proteogenomic analysis of right-sided colon cancer left-sided colon cancer and rectal cancer reveals distinct mutational profiles

机译:右侧结肠癌左侧结肠癌和直肠癌的蛋白质组学比较分析显示出明显的突变特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Right-sided colon cancer (RCC) has worse prognosis compared to left-sided colon cancer (LCC) and rectal cancer. The reason for this difference in outcomes is not well understood. We performed comparative somatic and proteomic analyses of RCC, LCC and rectal cancers to understand the unique molecular features of each tumor sub-types. Utilizing a novel in silico clonal evolution algorithm, we identified common tumor-initiating events involving APC, KRAS and TP53 genes in RCC, LCC and rectal cancers. However, the individual role-played by each event, their order in tumor development and selection of downstream somatic alterations were distinct in all three anatomical locations. Some similarities were noted between LCC and rectal cancer. Hotspot mutation analysis identified a nonsense mutation, APC R1450* specific to RCC. In addition, we discovered new significantly mutated genes at each tumor location, Further in silico proteomic analysis, developed by our group, found distinct central or hub proteins with unique interactomes among each location. Our study revealed significant differences between RCC, LCC and rectal cancers not only at somatic but also at proteomic level that may have therapeutic relevance in these highly complex and heterogeneous tumors.Electronic supplementary materialThe online version of this article (10.1186/s12943-018-0923-9) contains supplementary material, which is available to authorized users.
机译:与左侧结肠癌(LCC)和直肠癌相比,右侧结肠癌(RCC)的预后更差。结果差异的原因尚不清楚。我们进行了RCC,LCC和直肠癌的体细胞和蛋白质组学比较分析,以了解每种肿瘤亚型的独特分子特征。利用一种新颖的计算机克隆进化算法,我们确定了在RCC,LCC和直肠癌中涉及APC,KRAS和TP53基因的常见肿瘤引发事件。然而,每个事件的个体角色,它们在肿瘤发展中的顺序以及下游体细胞变化的选择在所有三个解剖位置上都是不同的。 LCC和直肠癌之间存在一些相似之处。热点突变分析确定了无意义的突变,即RCC特有的APC R1450 *。此外,我们在每个肿瘤部位发现了新的显着突变的基因。由我们小组开发的进一步的计算机蛋白质组学分析发现,在每个部位之间具有独特的相互作用组的独特的中央或集线蛋白。我们的研究揭示了RCC,LCC和直肠癌之间的显着差异,不仅在体细胞方面,而且在蛋白质组学上也可能对这些高度复杂和异质性肿瘤具有治疗意义。电子补充材料本文的在线版本(10.1186 / s12943-018-0923 -9)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号